CVE-2025-59094A local privilege escalation vulnerability has been identified in the Kaba exos 9300 System management application (d9sysdef.exe).
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
A local privilege escalation vulnerability has been identified in the Kaba exos 9300 System management application (d9sysdef.exe). Within this application it is possible to specify an arbitrary executable as well as the weekday and start time, when the specified executable should be run with SYSTEM privileges.
- CVSS
- 8.4 HIGH (v4.0, NVD)CVSS:4.0/AV:L/AC:L/AT:N/PR:H/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
- Weakness (CWE)
- CWE-269
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jun 17, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://r.sec-consult.com/dkexos
- https://r.sec-consult.com/dormakaba
- https://www.dormakabagroup.com/en/security-advisories
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.